Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Maraganore John
Relationship:   Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   263,534    

Indirect Shares

   6,153,633      
Direct Value   $34,888,515    

Indirect Value

   $14,549,676      
Total Shares   6,417,167      
Total Value   $49,438,191      


Alnylam Pharmaceuticals Inc $33,792,019 Agios Pharmaceuticals Inc $1,091,218 Bluebird Bio, Inc. $5,279 Alnylam Pharmaceuticals Inc $33,792,019 Agios Pharmaceuticals Inc $1,091,218 Bluebird Bio, Inc. $5,279
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Alnylam Pharmaceuticals Inc ALNY Chief Executive Office... 2021-12-22 227,663 2021-12-22 3,133    Premium*  
            Regulus Therapeutics Inc. RGLS Director, 10% Owner 2012-10-10 0 2012-10-10 6,150,500    Premium*  
            Agios Pharmaceuticals Inc AGIO Director 2022-05-20 30,028 0    Premium*  
            Bluebird Bio, Inc. BLUE Director 2017-09-14 5,843 2014-07-14 0    Premium*  
* Premium Members only  

Records found :    154         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BLUE Bluebird Bio, Inc. Director   –       •      –    2017-09-14 4 S $131.19 $2,475,733 D/D (18,868) 5,843 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2017-11-15 4 OE $31.39 $2,322,860 D/D 74,000 223,710 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2017-11-15 4 AS $125.54 $9,387,951 D/D (74,000) 149,710 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2017-11-22 4 AS $129.97 $9,609,736 D/D (73,415) 149,710 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2017-11-22 4 OE $31.39 $2,304,497 D/D 73,415 223,125 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2017-12-19 4 OE $63.00 $99,981 D/D 1,587 151,297 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2018-04-16 4 A $0.00 $0 I/I 30 2,990 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2018-07-10 4 A $0.00 $0 I/I 31 3,021 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2018-07-25 4 AS $102.51 $5,269,457 D/D (50,000) 151,297 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2018-07-25 4 OE $21.35 $1,067,500 D/D 50,000 201,297 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2018-09-11 4 S $72.52 $986,129 D/D (13,555) 36,209 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2018-09-12 4 S $71.74 $1,015,982 D/D (14,162) 22,047 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2018-10-18 4 A $0.00 $0 I/I 17 3,038 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2018-11-21 4 OE $21.35 $2,105,879 D/D 98,636 249,933 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2018-11-21 4 D $72.68 $4,356,439 D/D (59,940) 189,993 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2019-04-09 4 A $0.00 $0 I/I 61 3,099 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2019-05-15 4 AS $70.00 $3,461,990 D/D (49,457) 189,993 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2019-05-15 4 OE $16.43 $812,579 D/D 49,457 239,450 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2019-05-31 4 OE $0.00 $0 D/D 1,400 37,609 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2019-06-12 4 GD $0.00 $0 D/D 5,000 32,609 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2019-07-11 4 A $0.00 $0 I/I 34 3,133 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2019-10-14 4 OE $16.43 $812,562 D/D 49,456 239,449 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2019-10-14 4 AS $78.92 $3,929,210 D/D (49,456) 189,993 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2020-02-14 4 GD $0.00 $0 D/D 4,315 28,294 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2020-02-20 4 AS $128.62 $4,583,674 D/D (34,765) 189,993 0 %
  154  Records found
  1   2   3   4   5  6   7      
  Page 5 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us